Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
The association of the major histocompatibility complex (MHC) genes with autoimmune diseases together with the ectopic expression of class II molecules by epithelial cells of the target tissue gives to these molecules a central role in the pathogenesis of the disease, in its regulation and in the persistence of the immune response in situ. HLA-DR molecules expressed by thyroid follicular cells in thyroid autoimmune diseases are compact molecules stably associated with peptides. The nature of these peptides is of vital importance in the understanding of the disease, since these MHC-II-peptide complexes are going to be recognized by both effector and regulatory T cells in situ. In this chapter, we review the current state of the analysis of naturally processed peptides presented by MHC class II molecules in the context of autoimmunity and we discuss our data of natural HLA-DR ligands eluted from Graves' disease affected thyroid glands, from where autoantigen-derived peptides have been identified.
Muixí
Laia
L
Immunology Unit, Institut de Biotechnologia i Biomedicina, Universitat Autònoma de Barcelona, Campus de Bellaterra, Barcelona, Spain.
Alvarez
Iñaki
I
Jaraquemada
Dolores
D
D000818:Animals; D017951:Antigen Presentation; D015551:Autoimmunity; D006111:Graves Disease / Q000209:etiology / Q000276:immunology* / Q000378:metabolism; D006684:HLA-DR Antigens / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D010455:Peptides / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism; D013961:Thyroid Gland / Q000276:immunology* / Q000378:metabolism
D006684:HLA-DR Antigens; D010455:Peptides